Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation

Purpose: Coronary artery disease (CAD) and atrial fibrillation (AF) often coexist and lead to a much higher risk of mortality in the elderly population. The aim of this study was to investigate whether the CHA2DS2-VASc score could predict the risk of death in elderly patients with CAD and AF.Methods...

Full description

Bibliographic Details
Main Authors: Yangxun Wu, Guanyun Wang, Lisha Dong, Liu'an Qin, Jian Li, Hengming Yan, Wenjie Guo, Xiaodong Feng, Yuting Zou, Ziqian Wang, Rina Du, Yuxiao Zhang, Jing Ma, Tong Yin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.805234/full
_version_ 1818966262717349888
author Yangxun Wu
Yangxun Wu
Guanyun Wang
Guanyun Wang
Lisha Dong
Liu'an Qin
Liu'an Qin
Jian Li
Hengming Yan
Wenjie Guo
Xiaodong Feng
Yuting Zou
Yuting Zou
Ziqian Wang
Ziqian Wang
Rina Du
Yuxiao Zhang
Jing Ma
Tong Yin
Tong Yin
author_facet Yangxun Wu
Yangxun Wu
Guanyun Wang
Guanyun Wang
Lisha Dong
Liu'an Qin
Liu'an Qin
Jian Li
Hengming Yan
Wenjie Guo
Xiaodong Feng
Yuting Zou
Yuting Zou
Ziqian Wang
Ziqian Wang
Rina Du
Yuxiao Zhang
Jing Ma
Tong Yin
Tong Yin
author_sort Yangxun Wu
collection DOAJ
description Purpose: Coronary artery disease (CAD) and atrial fibrillation (AF) often coexist and lead to a much higher risk of mortality in the elderly population. The aim of this study was to investigate whether the CHA2DS2-VASc score could predict the risk of death in elderly patients with CAD and AF.Methods: Hospitalized patients aged ≥65 years with a diagnosis of CAD and AF were recruited consecutively. Patients were divided into 5 groups according to the CHA2DS2-VASc score (≤2, =3, =4, =5, and ≥6). At least a 1-year follow-up was carried out for the assessment of all-cause death.Results: A total of 1,579 eligible patients were recruited, with 582 all-cause deaths (6.86 per 100 patient-years) occurring during a follow-up of at least 1 year. With the increase in the CHA2DS2-VASc score, the 1-year and 5-year survival rate decreased (96.4% vs. 95.7% vs. 94.0% vs. 86.5% vs. 85.7%, respectively, P < 0.001; 78.4% vs. 68.9% vs. 64.6% vs. 55.5% vs. 50.0%, respectively, P < 0.001). Compared with the patients with CHA2DS2-VASc score <5, for patients with CHA2DS2-VASc score ≥5, the adjusted hazard ratio for death was 1.78 (95% CI: 1.45–2.18, P < 0.001). The predictive values of the CHA2DS2-VASc score ≥5 for in-hospital (C-index = 0.66, 95% CI: 0.62–0.69, P < 0.001), 1-year (C-index = 0.65, 95% CI: 0.63–0.67, P < 0.001) and 5-year (C-index = 0.60, 95% CI: 0.59–0.61, P < 0.001) death were in comparable.Conclusion: In elderly patients with concomitant CAD and AF, the CHA2DS2-VASc score can be used to predict death with moderate accuracy.
first_indexed 2024-12-20T13:30:07Z
format Article
id doaj.art-e237fab274ad419e8fe1e0c58b6546db
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-20T13:30:07Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-e237fab274ad419e8fe1e0c58b6546db2022-12-21T19:39:07ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-12-01810.3389/fcvm.2021.805234805234Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial FibrillationYangxun Wu0Yangxun Wu1Guanyun Wang2Guanyun Wang3Lisha Dong4Liu'an Qin5Liu'an Qin6Jian Li7Hengming Yan8Wenjie Guo9Xiaodong Feng10Yuting Zou11Yuting Zou12Ziqian Wang13Ziqian Wang14Rina Du15Yuxiao Zhang16Jing Ma17Tong Yin18Tong Yin19Institute of Geriatrics, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Medical School of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Medical School of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Medical School of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing, ChinaInstitute of Geriatrics, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Medical School of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Medical School of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Medical School of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, National Clinical Research Center for Geriatric Diseases, 2nd Medical Center, Medical School of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing, ChinaDepartment of Cardiology, 1st Medical Center, Medical School of Chinese PLA and Chinese PLA General Hospital, Beijing, ChinaPurpose: Coronary artery disease (CAD) and atrial fibrillation (AF) often coexist and lead to a much higher risk of mortality in the elderly population. The aim of this study was to investigate whether the CHA2DS2-VASc score could predict the risk of death in elderly patients with CAD and AF.Methods: Hospitalized patients aged ≥65 years with a diagnosis of CAD and AF were recruited consecutively. Patients were divided into 5 groups according to the CHA2DS2-VASc score (≤2, =3, =4, =5, and ≥6). At least a 1-year follow-up was carried out for the assessment of all-cause death.Results: A total of 1,579 eligible patients were recruited, with 582 all-cause deaths (6.86 per 100 patient-years) occurring during a follow-up of at least 1 year. With the increase in the CHA2DS2-VASc score, the 1-year and 5-year survival rate decreased (96.4% vs. 95.7% vs. 94.0% vs. 86.5% vs. 85.7%, respectively, P < 0.001; 78.4% vs. 68.9% vs. 64.6% vs. 55.5% vs. 50.0%, respectively, P < 0.001). Compared with the patients with CHA2DS2-VASc score <5, for patients with CHA2DS2-VASc score ≥5, the adjusted hazard ratio for death was 1.78 (95% CI: 1.45–2.18, P < 0.001). The predictive values of the CHA2DS2-VASc score ≥5 for in-hospital (C-index = 0.66, 95% CI: 0.62–0.69, P < 0.001), 1-year (C-index = 0.65, 95% CI: 0.63–0.67, P < 0.001) and 5-year (C-index = 0.60, 95% CI: 0.59–0.61, P < 0.001) death were in comparable.Conclusion: In elderly patients with concomitant CAD and AF, the CHA2DS2-VASc score can be used to predict death with moderate accuracy.https://www.frontiersin.org/articles/10.3389/fcvm.2021.805234/fullelderlyatrial fibrillationcoronary artery diseasedeathCHA2DS2-VASc score
spellingShingle Yangxun Wu
Yangxun Wu
Guanyun Wang
Guanyun Wang
Lisha Dong
Liu'an Qin
Liu'an Qin
Jian Li
Hengming Yan
Wenjie Guo
Xiaodong Feng
Yuting Zou
Yuting Zou
Ziqian Wang
Ziqian Wang
Rina Du
Yuxiao Zhang
Jing Ma
Tong Yin
Tong Yin
Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
Frontiers in Cardiovascular Medicine
elderly
atrial fibrillation
coronary artery disease
death
CHA2DS2-VASc score
title Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
title_full Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
title_fullStr Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
title_full_unstemmed Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
title_short Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
title_sort assessment of the cha2ds2 vasc score for the prediction of death in elderly patients with coronary artery disease and atrial fibrillation
topic elderly
atrial fibrillation
coronary artery disease
death
CHA2DS2-VASc score
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.805234/full
work_keys_str_mv AT yangxunwu assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT yangxunwu assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT guanyunwang assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT guanyunwang assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT lishadong assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT liuanqin assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT liuanqin assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT jianli assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT hengmingyan assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT wenjieguo assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT xiaodongfeng assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT yutingzou assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT yutingzou assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT ziqianwang assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT ziqianwang assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT rinadu assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT yuxiaozhang assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT jingma assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT tongyin assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation
AT tongyin assessmentofthecha2ds2vascscoreforthepredictionofdeathinelderlypatientswithcoronaryarterydiseaseandatrialfibrillation